Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis.

Khan K, Xu S, Nihtyanova S, Derrett-Smith E, Abraham D, Denton CP, Ong VH.

Ann Rheum Dis. 2012 Jul;71(7):1235-42. doi: 10.1136/annrheumdis-2011-200955. Epub 2012 May 14.

PMID:
22586157
[PubMed - indexed for MEDLINE]
2.

Increased serum pentraxin 3 in patients with systemic sclerosis.

Iwata Y, Yoshizaki A, Ogawa F, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Takehara K, Sato S.

J Rheumatol. 2009 May;36(5):976-83. doi: 10.3899/jrheum.080343. Epub 2009 Feb 27.

PMID:
19273457
[PubMed - indexed for MEDLINE]
3.

Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis.

Kudo H, Jinnin M, Asano Y, Trojanowska M, Nakayama W, Inoue K, Honda N, Kajihara I, Makino K, Fukushima S, Ihn H.

Arthritis Rheumatol. 2014 Jun;66(6):1636-47. doi: 10.1002/art.38380.

PMID:
24470401
[PubMed - indexed for MEDLINE]
4.

A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response.

Masui Y, Asano Y, Shibata S, Noda S, Akamata K, Aozasa N, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Yanaba K, Tada Y, Sugaya M, Sato S, Kadono T.

Rheumatology (Oxford). 2013 Jul;52(7):1239-44. doi: 10.1093/rheumatology/ket010. Epub 2013 Feb 26.

PMID:
23443327
[PubMed - indexed for MEDLINE]
5.

Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor β.

Christmann RB, Mathes A, Affandi AJ, Padilla C, Nazari B, Bujor AM, Stifano G, Lafyatis R.

Arthritis Rheum. 2013 May;65(5):1335-46. doi: 10.1002/art.37859.

PMID:
23335246
[PubMed - indexed for MEDLINE]
Free Article
6.

Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.

Farina G, Lemaire R, Pancari P, Bayle J, Widom RL, Lafyatis R.

Ann Rheum Dis. 2009 Mar;68(3):435-41. doi: 10.1136/ard.2007.086850. Epub 2008 Apr 13.

PMID:
18408251
[PubMed - indexed for MEDLINE]
7.

Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.

Noda S, Asano Y, Aozasa N, Akamata K, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Kadono T, Sato S.

Arch Dermatol Res. 2013 May;305(4):325-31. doi: 10.1007/s00403-012-1307-4. Epub 2012 Dec 12.

PMID:
23233281
[PubMed - indexed for MEDLINE]
8.

Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.

Muangchan C, Harding S, Khimdas S, Bonner A; Canadian Scleroderma Research group, Baron M, Pope J.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716.

PMID:
22556030
[PubMed - indexed for MEDLINE]
9.

Increased serum soluble CD40 levels in patients with systemic sclerosis.

Komura K, Fujimoto M, Matsushita T, Yanaba K, Kodera M, Kawasuji A, Hasegawa M, Takehara K, Sato S.

J Rheumatol. 2007 Feb;34(2):353-8. Epub 2007 Jan 15.

PMID:
17295440
[PubMed - indexed for MEDLINE]
10.

Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.

Postiglione L, Ladogana P, Montagnani S, di Spigna G, Castaldo C, Turano M, Bruno EM, Di Meglio F, Riccio A, Rossi G.

J Rheumatol. 2005 Apr;32(4):656-64.

PMID:
15801021
[PubMed - indexed for MEDLINE]
11.

Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.

Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA Jr.

Arthritis Rheum. 2007 Aug;56(8):2740-6.

PMID:
17665460
[PubMed - indexed for MEDLINE]
Free Article
12.

Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.

Avouac J, Clemessy M, Distler JH, Gasc JM, Ruiz B, Vacher-Lavenu MC, Wipff J, Kahan A, Boileau C, Corvol P, Allanore Y.

Rheumatology (Oxford). 2011 Aug;50(8):1494-504. doi: 10.1093/rheumatology/keq448. Epub 2011 Mar 30.

PMID:
21454305
[PubMed - indexed for MEDLINE]
Free Article
13.

Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.

Carulli MT, Ong VH, Ponticos M, Shiwen X, Abraham DJ, Black CM, Denton CP.

Arthritis Rheum. 2005 Dec;52(12):3772-82.

PMID:
16320328
[PubMed - indexed for MEDLINE]
Free Article
14.

Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.

Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.

Arthritis Rheum. 2004 Jan;50(1):216-26.

PMID:
14730619
[PubMed - indexed for MEDLINE]
Free Article
15.

Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.

Iannone F, Matucci-Cerinic M, Falappone PC, Guiducci S, Cinelli M, Distler O, Lapadula G.

J Rheumatol. 2005 Oct;32(10):1893-8.

PMID:
16206343
[PubMed - indexed for MEDLINE]
16.

Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.

Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S.

J Rheumatol. 2006 Feb;33(2):275-84.

PMID:
16465658
[PubMed - indexed for MEDLINE]
17.

Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score.

Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP.

Rheumatology (Oxford). 2005 Dec;44(12):1518-24. Epub 2005 Sep 13.

PMID:
16159952
[PubMed - indexed for MEDLINE]
Free Article
18.

A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.

Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S.

Arthritis Rheum. 2006 Dec;54(12):3939-44.

PMID:
17133607
[PubMed - indexed for MEDLINE]
Free Article
19.

Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.

Sato S, Hasegawa M, Takehara K.

J Dermatol Sci. 2001 Oct;27(2):140-6.

PMID:
11532378
[PubMed - indexed for MEDLINE]
20.

Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.

Taniguchi T, Asano Y, Akamata K, Noda S, Masui Y, Yamada D, Takahashi T, Ichimura Y, Toyama T, Tamaki Z, Tada Y, Sugaya M, Kadono T, Sato S.

J Rheumatol. 2012 Mar;39(3):539-44. doi: 10.3899/jrheum.110755. Epub 2012 Jan 15.

PMID:
22247367
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk